98 related articles for article (PubMed ID: 16264407)
1. Loss of heterozygosity in 73 human thyroid tumors.
Wozniak A; Wiench M; Olejniczak A; Wloch J; Lachinski A; Lange D; Olczyk T; Jarzab B; Limon J
Neuro Endocrinol Lett; 2005 Oct; 26(5):521-5. PubMed ID: 16264407
[TBL] [Abstract][Full Text] [Related]
2. Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors.
Zhang JS; Nelson M; McIver B; Hay ID; Goellner JR; Grant CS; Eberhardt NL; Smith DI
Oncogene; 1998 Aug; 17(6):789-93. PubMed ID: 9715281
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer.
Trovato M; Fraggetta F; Villari D; Batolo D; Mackey K; Trimarchi F; Benvenga S
J Clin Endocrinol Metab; 1999 Sep; 84(9):3235-40. PubMed ID: 10487693
[TBL] [Abstract][Full Text] [Related]
4. RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan).
Nakazawa T; Kondo T; Kobayashi Y; Takamura N; Murata S; Kameyama K; Muramatsu A; Ito K; Kobayashi M; Katoh R
Cancer; 2005 Sep; 104(5):943-51. PubMed ID: 16015630
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations in papillary thyroid carcinoma and hashimoto thyroiditis: An analysis of hOGG1 loss of heterozygosity.
Royer MC; Zhang H; Fan CY; Kokoska MS
Arch Otolaryngol Head Neck Surg; 2010 Mar; 136(3):240-2. PubMed ID: 20231640
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity on chromosome 16p and 18q in anaplastic thyroid carcinoma.
Kadota M; Tamaki Y; Sekimoto M; Fujiwara Y; Aritake N; Hasegawa S; Kobayashi T; Ikeda T; Horii A; Monden M
Oncol Rep; 2003; 10(1):35-8. PubMed ID: 12469141
[TBL] [Abstract][Full Text] [Related]
7. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers.
Herrmann MA; Hay ID; Bartelt DH; Ritland SR; Dahl RJ; Grant CS; Jenkins RB
J Clin Invest; 1991 Nov; 88(5):1596-604. PubMed ID: 1939648
[TBL] [Abstract][Full Text] [Related]
9. Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas.
McCarthy RP; Wang M; Jones TD; Strate RW; Cheng L
Clin Cancer Res; 2006 Apr; 12(8):2414-8. PubMed ID: 16638846
[TBL] [Abstract][Full Text] [Related]
10. Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.
Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S
J Pathol; 2008 May; 215(1):87-96. PubMed ID: 18306168
[TBL] [Abstract][Full Text] [Related]
11. Caveolin-1 and caveolin-2,together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis.
Aldred MA; Ginn-Pease ME; Morrison CD; Popkie AP; Gimm O; Hoang-Vu C; Krause U; Dralle H; Jhiang SM; Plass C; Eng C
Cancer Res; 2003 Jun; 63(11):2864-71. PubMed ID: 12782592
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of multifocal papillary thyroid carcinoma.
Lin X; Finkelstein SD; Zhu B; Silverman JF
J Mol Endocrinol; 2008 Oct; 41(4):195-203. PubMed ID: 18628356
[TBL] [Abstract][Full Text] [Related]
13. RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma.
Corvi R; Berger N; Balczon R; Romeo G
Oncogene; 2000 Aug; 19(37):4236-42. PubMed ID: 10980597
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity in follicular and papillary thyroid carcinomas.
Rodrigues-Serpa A; Catarino A; Soares J
Cancer Genet Cytogenet; 2003 Feb; 141(1):26-31. PubMed ID: 12581895
[TBL] [Abstract][Full Text] [Related]
15. [Loss of heterozygosity on chromosome 3p in thyroid tumors].
Hu MJ; Xu HD; Zhou R; Li XF; Zhang HY
Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):305-8. PubMed ID: 18956647
[TBL] [Abstract][Full Text] [Related]
16. Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas.
Ward LS; Brenta G; Medvedovic M; Fagin JA
J Clin Endocrinol Metab; 1998 Feb; 83(2):525-30. PubMed ID: 9467569
[TBL] [Abstract][Full Text] [Related]
17. Distinct genetic changes characterise multifocality and diverse histological subtypes in papillary thyroid carcinoma.
Jovanovic L; Delahunt B; McIver B; Eberhardt NL; Bhattacharya A; Lea R; Grebe SK
Pathology; 2010; 42(6):524-33. PubMed ID: 20854070
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma.
Lam AK; Lo CY; Leung P; Lang BH; Chan WF; Luk JM
Ann Surg Oncol; 2007 May; 14(5):1772-9. PubMed ID: 17195959
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological Significance of Overall Frequency of Allelic Loss (OFAL) in Lesions Derived from Thyroid Follicular Cell.
Migdalska-Sęk M; Czarnecka KH; Kusiński M; Pastuszak-Lewandoska D; Nawrot E; Kuzdak K; Brzeziańska-Lasota E
Mol Diagn Ther; 2019 Jun; 23(3):369-382. PubMed ID: 30747408
[TBL] [Abstract][Full Text] [Related]
20. Allelotype of follicular thyroid carcinomas reveals genetic instability consistent with frequent nondisjunctional chromosomal loss.
Tung WS; Shevlin DW; Kaleem Z; Tribune DJ; Wells SA; Goodfellow PJ
Genes Chromosomes Cancer; 1997 May; 19(1):43-51. PubMed ID: 9135994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
